Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance

• US 8,200,326 B2
• Filed: 09/10/2009
• Issued: 06/12/2012
• Est. Priority Date: 04/26/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Hatlestad, John D., Moon, Loell Boyce, Hartley, Jesse W., Stahmann, Jeffrey E.
• Primary Examiner(s): Mallari, Patricia
• Assistant Examiner(s): JANG, CHRISTIAN YONGKYUN
• Application Number:
  US12/557,372
• Publication Number:
  US 20090326599A1
• Time in Patent Office: 1,006 Days
• Field of Search: 600/538, 600/547, 607/17, 607/20
• US Class Current: 600/547
• CPC Class Codes: A61B 2560/0223 of calibration, e.g. protocols for calibrating sensors
• CPC Class Codes: A61B 5/0809 by impedance pneumography
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators

Abstract

A system includes an implantable medical device that includes a trans-thoracic impedance measurement circuit providing a trans-thoracic impedance signal of a subject. A controller is coupled to the trans-thoracic impedance circuit. The controller extracts a respiration signal from the trans-thoracic impedance signal, measures a breathing volume of the subject using the amplitude of the respiration signal and a breathing volume calibration factor, computes an adjusted breathing volume calibration factor using a reference baseline value of the trans-thoracic impedance and a measured baseline value of the trans-thoracic impedance, and computes a calibrated breathing volume using the adjusted breathing volume calibration factor.

Claims

1. A method comprising:

detecting a change in direct current (DC) trans-thoracic impedance;

adjusting a breathing volume calibration factor in accordance with the change in DC trans-thoracic impedance, wherein the breathing volume calibration factor translates a measure of impedance to a measure of breathing volume, and the adjusted breathing volume calibration factor includes a ratio of a reference DC trans-thoracic impedance to a more recently measured value of the DC trans-thoracic impedance; and

measuring breathing volume of a patient using the implantable medical device, the medical device adjusting the measured breathing volume using the breathing volume calibration factor.

2. The method of claim 1, wherein adjusting the breathing volume calibration factor includes adjusting using the ratio of a reference DC impedance and the more recently measured DC impedance, and wherein measuring breathing volume includes calibrating a raw measurement of breathing volume using the breathing volume calibration factor.

3. The method of claim 1, wherein measuring breathing volume includes measuring trans-thoracic impedance.

4. The method of claim 1, wherein detecting the change in DC trans-thoracic impedance includes monitoring DC trans-thoracic impedance over time.

5. The method of claim 1, wherein the breathing volume calibration factor associates a measurement of ohms-per-breath with a measurement of volume-per-breath.

6. The method of claim 1, wherein detecting the change in DC trans-thoracic impedance includes determining a baseline DC trans-thoracic impedance and detecting changes in impedance from the baseline DC trans-thoracic impedance.

7. The method of claim 1, wherein adjusting the breathing volume calibration factor includes using the change in DC trans-thoracic impedance measured while the patient is in a first patient posture.

8. The method of claim 1, wherein detecting a change in DC trans-thoracic impedance includes:

determining a first baseline DC trans-thoracic impedance for a first patient posture and a second baseline DC trans-thoracic impedance for at least a second patient posture; and

detecting changes in impedance from the first baseline impedance when the patient is in the first posture and detecting changes in impedance from the second baseline impedance when the patient is in the second posture.

9. The method of claim 1, wherein measuring breathing volume using an implantable medical device includes monitoring breathing volume with a cardiac rhythm management device.

10. The method of claim 9, wherein the method further includes changing a pacing rate of the cardiac rhythm management device in response to the measured breathing volume.

11. The method of claim 1, wherein the method further includes storing trending information related to DC trans-thoracic impedance.

12. The method of claim 1, wherein the method further includes storing trending information related to breathing volumes.

13. The method of claim 1, wherein the method further includes communicating trending information related to one or both of the DC trans-thoracic impedance and the breathing volume to an external device for display.

14. The method of claim 1, wherein the method further includes communicating DC trans-thoracic impedance information to an external device connected to a computer network.

15. A method comprising:

measuring a direct current (DC) component of a trans-thoracic impedance signal of a subject using an implantable medical device;

adjusting a breathing volume calibration factor using a reference baseline value of the DC component of the trans-thoracic impedance and a measured change from the reference baseline value of the DC component of the trans-thoracic impedance, wherein the breathing volume calibration factor translates a measure of impedance to a measure of breathing volume, and the adjusted breathing volume calibration factor includes a ratio of a reference DC trans-thoracic impedance to a more recently measured value of the DC component of the trans-thoracic impedance;

extracting a respiration signal from the trans-thoracic impedance signal, the respiration signal including the DC component of the trans-thoracic impedance that is modulated by a breathing of the subject, the respiration signal including an amplitude; and

computing, using the implantable medical device, a breathing volume of the subject using the amplitude of the respiration signal and a breathing volume calibration factor.

16. The method of claim 15, wherein extracting the respiration signal includes filtering the trans-thoracic impedance signal to attenuate frequencies higher than 0.5 Hz.

17. The method of claim 15, wherein computing the breathing volume of the subject using the amplitude of the respiration signal includes measuring breathing volume using a peak-to-peak amplitude.

18. The method of claim 15, wherein the reference baseline value and the change from the reference baseline value are measured for a first patient posture.

19. The method of claim 15, wherein computing the breathing volume calibration factor includes computing the calibration factor using a measure of hematocrit in blood of the subject.

20. The method of claim 15, wherein computing the breathing volume calibration factor includes computing the calibration factor using a measure of resistivity of blood within a heart.

21. The method of claim 15, wherein the reference baseline value of the trans-thoracic impedance includes a DC trans-thoracic impedance value measured over a period of time.

22. The method of claim 15, wherein the calibrated breathing volume is computed by multiplying the measured breathing volume by the breathing volume calibration factor.